Bayard Powell to Blast Crisis
This is a "connection" page, showing publications Bayard Powell has written about Blast Crisis.
Connection Strength
0.106
-
Nicolini FE, Masszi T, Shen Z, Gallagher NJ, Jootar S, Powell BL, Dorlhiac-Llacer PE, Zheng M, Szczudlo T, Turkina A. Expanding Nilotinib Access in Clinical Trials (ENACT), an open-label multicenter study of oral nilotinib in adult patients with imatinib-resistant or -intolerant chronic myeloid leukemia in accelerated phase or blast crisis. Leuk Lymphoma. 2012 May; 53(5):907-14.
Score: 0.106